Elevance Health Inc’s recently made public that its EVP & President, Commercial Kendrick Charles Morgan JR unloaded Company’s shares for reported $1.22 million on Mar 08 ’24. In the deal valued at $500.46 per share,2,432 shares were sold. As a result of this transaction, Kendrick Charles Morgan JR now holds 15,840 shares worth roughly $8.43 million.
Then, Penczek Ronald W sold 916 shares, generating $462,195 in total proceeds. Upon selling the shares at $504.58, the CAO & Controller now owns 1,764 shares.
Before that, Haytaian Peter D sold 21,095 shares. Elevance Health Inc shares valued at $10,551,297 were divested by the EVP & Pres Carelon & CarelonRx at a price of $500.18 per share. As a result of the transaction, Haytaian Peter D now holds 18,887 shares, worth roughly $10.05 million.
Barclays initiated its Elevance Health Inc [ELV] rating to an Overweight in a research note published on March 06, 2024; the price target was $584. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in mid July from “an Outperform” to “a Peer perform”. Morgan Stanley also remained covering ELV and has increased its forecast on April 27, 2023 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Cantor Fitzgerald started covering the stock on April 21, 2023. It rated ELV as “an Overweight”.
Price Performance Review of ELV
On Monday, Elevance Health Inc [NYSE:ELV] saw its stock jump 0.15% to $532.22. Over the last five days, the stock has gained 6.42%. Elevance Health Inc shares have risen nearly 12.86% since the year began. Nevertheless, the stocks have risen 16.99% over the past one year. While a 52-week high of $539.11 was reached on 04/18/24, a 52-week low of $412.00 was recorded on 01/18/24. SMA at 50 days reached $509.27, while 200 days put it at $474.40. A total of 1.48 million shares were traded, compared to the trading of 1.79 million shares in the previous session.
Levels Of Support And Resistance For ELV Stock
The 24-hour chart illustrates a support level at 527.48, which if violated will result in even more drops to 522.73. On the upside, there is a resistance level at 536.94. A further resistance level may holdings at 541.65. The Relative Strength Index (RSI) on the 14-day chart is 65.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 19.01, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.38%. Stochastics %K at 79.03% indicates the stock is a holding.
